Trial intelligence / Profile preview

CBT plus sertraline versus CBT plus placebo for childhood and adolescent anxiety

ACTRN12613001059752Phase 4Completed

Sponsor
Professor Jennifer Hudson
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in anxiety disorder comparing CBT + sertraline with CBT + placebo (2 arms). Primary endpoints: Remission of primary anxiety diagnosis and Remission of any anxiety diagnosis. Started May 2014; status: completed.

02

Drugs

sertraline
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on ACTRN12613001059752.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613001059752.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call